Met Life Investment Management, LLC Paratek Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.81 - $10.93 $31,557 - $50,649	-4,634 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$6.14 - $8.31 $28,452 - $38,508	4,634 New	4,634 $32,000
Q1 2021 Jun 26, 2023	BUY	$6.14 - $8.31 $28,452 - $38,508	4,634 New	4,634 $32.7 Million
Q1 2021 Mar 22, 2023	SELL	$6.14 - $8.31 $98,890 - $133,840	-16,106 Reduced 77.66%	4,634 $32,000
Q1 2021 May 14, 2021	SELL	$6.14 - $8.31 $98,890 - $133,840	-16,106 Reduced 77.66%	4,634 $33,000
Q4 2020 May 24, 2024	SELL	$4.58 - $7.14 $2,120 - $3,305	-463 Reduced 2.18%	20,740 $129,000
Q4 2020 Jun 22, 2023	BUY	$4.58 - $7.14 $94,989 - $148,083	20,740 New	20,740 $129,000
Q4 2020 Mar 22, 2023	SELL	$4.58 - $7.14 $2,120 - $3,305	-463 Reduced 2.18%	20,740 $129,000
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $2,120 - $3,305	-463 Reduced 2.18%	20,740 $130,000
Q3 2020 May 24, 2024	SELL	$4.19 - $6.69 $1,131 - $1,806	-270 Reduced 1.26%	21,203 $115 Million
Q3 2020 Jun 26, 2023	BUY	$4.19 - $6.69 $88,840 - $141,848	21,203 New	21,203 $114,000
Q3 2020 Mar 22, 2023	SELL	$4.19 - $6.69 $1,131 - $1,806	-270 Reduced 1.26%	21,203 $114,000
Q3 2020 Nov 13, 2020	SELL	$4.19 - $6.69 $1,131 - $1,806	-270 Reduced 1.26%	21,203 $115,000
Q2 2020 May 24, 2024	BUY	$2.97 - $5.22 $63,774 - $112,089	21,473 New	21,473 $112 Million
Q2 2020 Jun 26, 2023	BUY	$2.97 - $5.22 $63,774 - $112,089	21,473 New	21,473 $112,000
Q2 2020 Mar 22, 2023	SELL	$2.97 - $5.22 $20,790 - $36,540	-7,000 Reduced 24.58%	21,473 $112,000
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $63,774 - $112,089	21,473 New	21,473 $112,000
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $136,670 - $330,286	-28,473 Closed	0 $0
Q3 2018 Jul 13, 2023	BUY	$9.05 - $10.95 $146,809 - $177,630	16,222 New	16,222 $157,000
Q3 2018 Mar 22, 2023	BUY	$9.05 - $10.95 $257,680 - $311,779	28,473 New	28,473 $276,000
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $110,871 - $134,148	12,251 Added 75.52%	28,473 $276,000
Q2 2018 Aug 15, 2018	BUY	$10.2 - $13.9 $60,128 - $81,940	5,895 Added 57.08%	16,222 $165,000
Q4 2017 Feb 15, 2018	BUY	$17.45 - $25.6 $180,206 - $264,371	10,327	10,327 $185,000

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account